TERBINAFINE BAILLEUL 250 mg, tablet 28 tablets
Active ingredients: Terbinafine hydrochloride, Terbinafine
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERBINAFINE BAILLEUL 250 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 28 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES BAILLEUL (LUXEMBOURG)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65940757CIP73854843CIP133400938548433Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TERBINAFINEcomprimé | 281,25 mg · un comprimé | SA |
| TERBINAFINEcomprimé | 250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.